URGN ▼ -10.2% - UroGen Pharma Ltd.
$URGN - UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights
04-NOV-2026 08:00 AM ET
Share this post
More filings for $URGN
URGN ▼ -8.5% - UroGen Pharma Ltd.Nov 4, 2026URGN ▲ +2.1% - UroGen Pharma Ltd.Nov 3, 2026URGN ▲ +1.2% - UroGen Pharma Ltd.Oct 28, 2026URGN - UroGen Pharma Ltd. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026URGN ▼ -0.4% - UroGen Pharma Ltd.Oct 27, 2026URGN ▼ -0.6% - UroGen Pharma Ltd.Sep 2, 2026
View full $URGN filing history →💬 Comments
Loading comments…
Leave a comment